Black Rock Inc. Codex Dna, Inc. Transaction History

Black Rock Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	N/A	-1,027 Reduced 3.97%	24,830 $45,000
Q4 2023 Feb 13, 2024	SELL	N/A	-302 Reduced 1.15%	25,857 $47,000
Q3 2023 Nov 13, 2023	SELL	N/A	-1,057 Reduced 3.88%	26,159 $48,000
Q2 2023 Aug 11, 2023	BUY	N/A	2,522 Added 10.21%	27,216 $50,000
Q1 2023 May 12, 2023	SELL	$1.3 - $2.15 $4,049 - $6,697	-3,115 Reduced 11.2%	24,694 $45,000
Q4 2022 Feb 13, 2023	SELL	$1.12 - $1.69 $81,040 - $122,285	-72,358 Reduced 72.24%	27,809 $33,000
Q3 2022 Nov 14, 2022	SELL	$1.7 - $2.36 $3,649 - $5,066	-2,147 Reduced 2.1%	100,167 $166,000
Q2 2022 Aug 12, 2022	SELL	$1.8 - $6.45 $662,751 - $2.37 Million	-368,195 Reduced 78.25%	102,314 $184,000
Q1 2022 May 12, 2022	SELL	$4.12 - $10.36 $55,949 - $140,688	-13,580 Reduced 2.81%	470,509 $2.53 Million
Q4 2021 Feb 10, 2022	BUY	$6.31 - $11.96 $950,399 - $1.8 Million	150,618 Added 45.17%	484,089 $5.23 Million
Q3 2021 Nov 09, 2021	BUY	$10.15 - $19.88 $1.36 Million - $2.65 Million	133,512 Added 66.77%	333,471 $3.71 Million
Q2 2021 Aug 11, 2021	BUY	$17.76 - $22.0 $3.55 Million - $4.4 Million	199,959 New	199,959 $4.4 Million

307

Ticker DNAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,518,200
Market Cap $54.6M
Description
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.